Giacomo di Nepi

Giacomo di Nepi currently works at Peptomyc SL, as Chairman from 2021, Zambon SpA, as Director, GeNeuro SA, as Non-Executive Director from 2015, Handicap International France, as Director, NTC SRL, as Non-Executive Director from 2015, and GeNeuro SA (Switzerland), as Independent Director from 2015.
Mr. di Nepi also formerly worked at Spexis Ltd., as Chief Executive Officer from 2016 to 2020, Takeda Pharmaceuticals U.S.A., Inc., as Chief Executive Officer from 2006 to 2008, Elanco Italia SpA, as Chief Executive Officer, InterMune, Inc., as Executive VP & Managing Director-Europe from 2013 to 2014, Farmabios SpA, as Non-Executive Director from 2009 to 2012, Kuros Biosciences Ltd., as Independent Non-Executive Director from 2017 to 2019, McKinsey & Co., Inc., as Partner from 1980 to 1996, and Farmindustria, as Vice President.
Mr. di Nepi received his Masters Business Admin degree in 1980 from INSEAD and undergraduate degree in 1978 from the University of Bocconi.